Presents One-Year Outcomes from the LANDMARK Randomized Controlled TrialVAPI, India, Nov. 25, 2025 /PRNewswire/ -- Underscoring India's rising influence in…
- The program focuses on antibiotic resistance in urinary tract infections (UTI-DR), with applications open until November 20; final awardees…
FRANKFURT, Germany, Aug. 08, 2025 (GLOBE NEWSWIRE) -- In response to recent outbreaks of Chikungunya fever, Anbio Biotechnology has announced…
Fully Unmanned— CURECA™, the 100% Automated Diagnostic System Defining the Future Gold Standard, Debuts in Chicago, July 28–31Unifying global diagnostic data…